心疾患・脳血管疾患
CATEGORY
2023.1.13
Genetic Risk Score for Intracranial Aneurysms: Prediction of Subarachnoid Hemorrhage and Role in Clinical Heterogeneity
2023.1.12
Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction
2023.1.12
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention
2023.1.16
Genome-Wide Association Study of Intracranial Artery Stenosis Followed by Phenome-Wide Association Study
2023.1.18
Genome-wide Association Studies Categorized by Class of Antihypertensive Drugs Reveal Complex Pathogenesis of Hypertension with Drug Resistance
2023.1.20
Genetic Risk Score of Cerebral Infarction in Atrial Fibrillation Genome-Wide Association Study
2022.1.31
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants
2022.1.25
Stroke genetics informs drug discovery and risk prediction across ancestries
2022.1.22
Large-scale genome-wide association study of coronary artery disease in genetically diverse populations
2022.1.21
Genetic analysis of right heart structure and function in 40,000 people
2022.1.12
A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study
2022.1.7
Genome-wide risk prediction of common diseases across ancestries in one million people
2021.1.19
A genome-wide association study identifies a novel candidate locus at the DLGAP1 gene with susceptibility to resistant hypertension in the Japanese population
2021.1.3
Genome-wide analysis identifies novel susceptibility loci for myocardial infarction
2020.1.29
Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors
2020.1.14
Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease
2020.1.12
Transethnic Meta-Analysis of Genome-Wide Association Studies Identifies Three New Loci and Characterizes Population-Specific Differences for Coronary Artery Disease
2019.1.24
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke
2019.1.19
A novel intragenic deletion in OPHN1 in a Japanese patient with Dandy-Walker malformation
2019.1.14
Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study
2019.1.8
Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis
2018.1.28
Genetics of the thrombomodulin-endothelial cell protein C receptor system and the risk of early-onset ischemic stroke
2018.1.20
Identification of LEF1 as a Susceptibility Locus for Kawasaki Disease in Patients Younger than 6 Months of Age
2018.1.14
Multi-ethnic genome-wide association study for atrial fibrillation
2018.1.11
Blood lipid-related low-frequency variants in LDLR and PCSK9 are associated with onset age and risk of myocardial infarction in Japanese
2018.1.3
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes
2017.1.22
Genetic Variants of RAMP2 and CLR are Associated with Stroke
2017.1.20
A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease
2017.1.17
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials
2017.1.7
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease
2017.1.6
Identification of six new genetic loci associated with atrial fibrillation in the Japanese population
2017.1.5
Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation
2016.1.19
Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities
2016.1.10
Shared Genetic Risk Factors of Intracranial, Abdominal, and Thoracic Aneurysms
2016.1.2
A functional SNP in FLT1 increases risk of coronary artery disease in a Japanese population
2024.1.8
Machine learning reveals heterogeneous associations between environmental factors and cardiometabolic diseases across polygenic risk scores
2024.1.7
Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome‐Wide Association and Mendelian Randomization Study
2024.1.7
Genetically proxied HTRA1 protease activity and circulating levels independently predict risk of ischemic stroke and coronary artery disease
2024.1.6
Polygenic risk score for blood pressure and lifestyle factors with overall and CVD mortality: a prospective cohort study in a Japanese population
2017.1.1
Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project
2024.1.5
RNF213 Variants, Vasospastic Angina, and Risk of Fatal Myocardial Infarction
2007.1.2
A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction
2009.3.22
Lack of association between variations of PDE4D and ischemic stroke in the Japanese population
2010.3.22
Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population
2010.3.22
Association study of the polymorphisms on chromosome 12p13 with atherothrombotic stroke in the Japanese population
2010.3.22
Genome-wide association study of intracranial aneurysm identifies three new risk loci
2010.3.22
Functional SNP of ARHGEF10 confers risk of atherothrombotic stroke
2011.3.22
Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk
2011.3.22
Impact of LIMK1, MMP2 and TNF-α variations for intracranial aneurysm in Japanese population
2011.3.22
SNPs on chromosome 5p15.3 associated with myocardial infarction in Japanese population